TNF-Alpha Levels in Tears: A Novel Biomarker to Assess the Degree of Diabetic Retinopathy
Table 1
Demographic and laboratory results of cohort.
Controls Healthy subjects
Cases
value
Diabetic patient
NPDR
PDR
No. of subjects
16
16
16
N.S.# N.S.*
Age, yrs (range)
53 (47–58)
54 (49–67)
59 (52–73)
Gender (M/F)
(8/8)
(9/7)
(10/6)
BMI (Kg/m2)
21 (19–26)
26 (20.3–40)#
28 (20.3–52)#
<0.05#
Glucose (mmol/L)
5.7 (4.9–6.1)
6.6 (5.8–6.3)
6.7 (6.1–7.2)
HbA1c (%)
5.6 (5.3–6.1)
7.2 (6.5–11.5)#
7.8 (7.2–12.5)#
<0.05#
DM duration (yrs)
Not available
#
<0.001# <0.05*
BUN (mg/dL)
15 (6–20)
30 (24–48)#
<0.001# <0.001*
Protein urine (mg/L)
5.3 (2.6–10)
10.6 (5.6–20)#
<0.001# <0.001*
GFR (mL/min/1.73 m2)
95 (73–91)
82 (46–89)#
<0.001# <0.001*
BMI: Body Mass Index; DM: Diabetes Mellitus; BUN: Blood Urea Nitrogen; GRF: Glomerular Filtration Rate. Mann-Whitney -test: diabetic patients versus controls; Wilcoxon signed-rank test: patients with PDR versus patients with NPDR; NS: not significant.